XRAY Director Acquires 2,638 Phantom Stock Shares April 20, 2026

Insider trading activity reveals a lot about executive confidence in their company’s future. When directors acquire shares, even phantom stock, it signals they believe in the business direction. On December 31, 2025, Jonathan Jay Mazelsky, a director at XRAY (DENTSPLY SIRONA Inc.), acquired 2,638 phantom stock units through the company’s Directors’ Deferred Compensation plan. This acquisition was reported to the SEC on January 2, 2026. The transaction represents a meaningful addition to his existing holdings, bringing his total phantom stock position to 14,382 units. Such insider acquisitions often reflect management’s positive outlook on company performance and shareholder value creation.

Understanding the Phantom Stock Award

Phantom stock is a deferred compensation tool that companies use to reward executives and directors. It mirrors real stock performance without actual share ownership. Jonathan Mazelsky’s acquisition of 2,638 phantom stock units occurred on December 31, 2025, as part of the Directors’ Deferred Compensation (DDC) plan.

What Is Phantom Stock?

Phantom stock represents a contractual right to receive cash or shares equal to the value of company stock at a future date. Directors use these awards as part of their compensation package. The units track the company’s stock price movements but don’t grant voting rights. This structure allows companies to reward loyalty while managing dilution concerns.

How the DDC Plan Works

DENTSPLY SIRONA’s Directors’ Deferred Compensation plan lets board members defer portions of their compensation. Awards accumulate over time and grow with company performance. Mazelsky’s 2,638-unit award reflects his continued service on the board. The phantom stock vests according to plan terms, typically upon retirement or separation from the company.

Insider Transaction Details and SEC Filing

The transaction was formally disclosed through a Form 4 filing with the Securities and Exchange Commission. This filing provides transparency into executive and director stock movements. Mazelsky’s acquisition details reveal important information about compensation structure and insider confidence.

Form 4 Filing Breakdown

The SEC filing shows Mazelsky acquired 2,638 phantom stock units on December 31, 2025. His total phantom stock holdings after the transaction reached 14,382 units. The filing was submitted on January 2, 2026, within the required two-business-day reporting window. Form 4 filings are mandatory for all insider transactions and provide real-time market transparency.

Transaction Classification

This transaction is classified as an “A-Award,” meaning it’s a grant or award of securities. Unlike purchases or sales, awards represent compensation decisions by the company. The transaction type indicates this was a planned compensation event, not a discretionary market trade. Award transactions often signal management’s confidence in long-term company direction.

What This Insider Activity Means for DENTSPLY SIRONA

Director acquisitions through compensation plans provide insight into management sentiment and company strategy. Mazelsky’s phantom stock award reflects DENTSPLY SIRONA’s commitment to retaining experienced board leadership. The transaction occurs at year-end, a typical timing for annual compensation grants.

Board Confidence and Retention

Directors who accumulate phantom stock demonstrate confidence in the company’s future performance. Mazelsky’s growing position, now at 14,382 units, shows sustained engagement with DENTSPLY SIRONA. Phantom stock awards align director interests with shareholder returns. When the stock price rises, phantom stock holders benefit financially, creating incentive alignment.

Market Context for XRAY

DENTSPLY SIRONA trades with a market cap of $2.5 billion, positioning it as a significant player in dental equipment and technology. Meyka AI rates XRAY a grade of B, reflecting solid fundamentals and sector performance. Director acquisitions at this scale suggest management views current valuations as attractive for long-term wealth creation. The phantom stock structure allows directors to participate in upside potential while maintaining flexibility.

Key Takeaways for Investors

Insider transactions provide valuable signals about executive and director sentiment toward company prospects. Mazelsky’s phantom stock acquisition represents a positive indicator of board-level confidence. Understanding these transactions helps investors assess management’s conviction in their business strategy.

Why Phantom Stock Matters

Phantom stock awards are real compensation with real value implications. Directors wouldn’t accept these awards unless they believed in future stock appreciation. The fact that Mazelsky’s holdings grew to 14,382 units shows sustained confidence over time. Investors should view such accumulation as a bullish signal from insiders.

Monitoring Insider Activity

Regular review of Form 4 filings helps investors stay informed about insider sentiment. DENTSPLY SIRONA’s insider activity provides transparency into board-level decision-making. When directors acquire shares or phantom stock, it often precedes positive company announcements. Tracking these transactions can provide early warning signals about management confidence levels.

Final Thoughts

Jonathan Mazelsky’s acquisition of 2,638 phantom stock units through DENTSPLY SIRONA’s Directors’ Deferred Compensation plan signals board-level confidence in the company’s direction. The transaction, completed on December 31, 2025, and reported via SEC Form 4 filing, brings his total phantom stock holdings to 14,382 units. Phantom stock awards align director interests with shareholder returns, creating incentive structures that reward long-term value creation. For investors monitoring XRAY, this insider activity represents a positive indicator of management sentiment. While phantom stock differs from direct share purchases, it demonstrates sustained executive engagement with the company’…

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Insider trading data is sourced from public SEC filings. This is not financial advice. Always conduct your own research and consult a licensed financial advisor before making investment decisions.